A population-based study of associations between preeclampsia and later cardiovascular risk factors


      Women with a history of preeclampsia are at increased lifetime risk for cardiovascular disease. Their offspring may carry similar risks. The aim was to study cardiovascular and metabolic risk factors 11 years after the delivery among women who were diagnosed with mild, moderate, or severe preeclampsia, and their offspring, compared with women without preeclampsia and their offspring.

      Study Design

      In a follow-up 11 years after a nested case-control study at birth, we studied 611 mother-offspring dyads, including 228 dyads with preeclampsia in the index pregnancy and 383 dyads without preeclampsia. Cardiovascular and metabolic risk profiles were assessed by serum lipids (total cholesterol, high-density lipoprotein [HDL] cholesterol, non-HDL cholesterol), insulin-related factors (glucose, insulin, and homeostasis assessment model for insulin resistance) and blood pressure in mothers and children.


      Among mothers with mild or moderate preeclampsia, levels of glucose, insulin, and homeostasis assessment model for insulin resistance were higher than in the nonpreeclampsia group and also higher compared with mothers with severe preeclampsia (all P < .05). HDL cholesterol was lower in mothers with mild or moderate preeclampsia (all P < .05), but other lipids did not substantially differ between the groups. Body mass index and blood pressure (systolic and diastolic) were also higher in the mild and moderate preeclampsia group compared with mothers without preeclampsia (all P < .05). Among the offspring, we found no clear differences in any blood analytes between the groups.


      Women with a previous diagnosis of mild or moderate, but not severe, preeclampsia may have an adverse metabolic and cardiovascular risk profile 11 years after the delivery.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hogberg U.
        The World Health Report 2005: “make every mother and child count”—including Africans.
        Scand J Public Health. 2005; 33: 409-411
        • Roberts C.L.
        • Ford J.B.
        • Algert C.S.
        • et al.
        Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study.
        BMJ Open. 2011; 1: e000101
        • Steegers E.A.P
        • von Dadelszen P.
        • Duvekot J.J.
        • Pijnenborg R.
        Lancet. 2010; 376: 631-644
        • Bellamy L.
        • Casas J.P.
        • Hingorani A.D.
        • Williams D.J.
        Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.
        BMJ. 2007; 335: 974
        • Sibai B.
        • Dekker G.
        • Kupferminc M.
        Lancet. 2005; 365: 785-799
        • Hernández-Díaz S.
        • Toh S.
        • Cnattingius S.
        Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study.
        BMJ. 2009; 338: b2255
        • Lykke J.A.
        • Langhoff-Roos J.
        • Sibai B.M.
        • Funai E.F.
        • Triche E.W.
        • Paidas M.J.
        Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother.
        Hypertension. 2009; 53: 944-951
        • Skjaerven R.
        • Wilcox A.J.
        • Klungsoyr K.
        • et al.
        Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study.
        BMJ. 2012; 345: e7677
        • Roberts J.M.
        • Gammill H.S.
        Preeclampsia: recent insights.
        Hypertension. 2005; 46: 1243-1249
        • Ogland B.
        • Vatten L.J.
        • Romundstad P.R.
        • Nilsen S.T.
        • Forman M.R.
        Pubertal anthropometry in sons and daughters of women with preeclamptic or normotensive pregnancies.
        Arch Dis Childh. 2009; 94: 855-859
        • Ogland B.
        • Forman M.R.
        • Romundstad P.R.
        • Nilsen S.T.
        • Vatten L.J.
        Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies.
        J Hypertens. 2009; 27: 2051-2054
        • Ogland B.
        • Nilsen S.T.
        • Forman M.R.
        • Vatten L.J.
        Pubertal development in daughters of women with pre-eclampsia.
        Arch Dis Childh. 2011; 96: 740-743
        • CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group
        CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women.
        Lancet. 1994; 343: 619-629
        • Vatten L.J.
        • Odegard R.A.
        • Nilsen S.T.
        • Salvesen K.A.
        • Austgulen R.
        Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight.
        Obstetr Gynecol. 2002; 99: 85-90
        • Odegard R.A.
        • Vatten L.J.
        • Nilsen S.T.
        • Salvesen K.A.
        • Austgulen R.
        Risk factors and clinical manifestations of pre-eclampsia.
        BJOG. 2000; 107: 1410-1416
        • Odegard R.A.
        • Vatten L.J.
        • Nilsen S.T.
        • Salvesen K.A.
        • Austgulen R.
        Preeclampsia and fetal growth.
        Obstet Gynecol. 2000; 96: 950-955
        • Odegard R.A.
        • Vatten L.J.
        • Nilsen S.T.
        • Salvesen K.A.
        • Austgulen R.
        Umbilical cord plasma leptin is increased in preeclampsia.
        Am J Obstet Gynecol. 2002; 186: 427-432
        • Odegard R.A.
        • Vatten L.J.
        • Nilsen S.T.
        • Salvesen K.A.
        • Vefring H.
        • Austgulen R.
        Umbilical cord plasma interleukin-6 and fetal growth restriction in preeclampsia: a prospective study in Norway.
        Obstet Gynecol. 2001; 98: 289-294
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Wallace T.M.
        • Levy J.C.
        • Matthews D.R.
        Use and abuse of HOMA modeling.
        Diabetes Care. 2004; 27: 1487-1495
        • Okland I.
        • Gjessing H.K.
        • Grottum P.
        • Eggebo T.M.
        • Eik-Nes S.H.
        A new population-based term prediction model vs. two traditional sample-based models: validation on 9046 ultrasound examinations.
        Ultrasound Obstet Gynecol. 2011; 37: 207-213
        • Rothman K.J.
        • Greenland S.
        • Lash T.L.
        Modern epidemiology.
        Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA2008
        • Irgens H.U.
        • Reisaeter L.
        • Irgens L.M.
        • Lie R.T.
        Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.
        BMJ. 2001; 323: 1213-1217
        • Ray J.G.
        • Vermeulen M.J.
        • Schull M.J.
        • Redelmeier D.A.
        Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study.
        Lancet. 2005; 366: 1797-1803
        • McDonald S.D.
        • Malinowski A.
        • Zhou Q.
        • Yusuf S.
        • Devereaux P.J.
        Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses.
        Am Heart J. 2008; 156: 918-930
        • Fraser A.
        • Nelson S.M.
        • Macdonald-Wallis C.
        • et al.
        Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children.
        Circulation. 2012; 125: 1367-1380
        • Funai E.F.
        • Friedlander Y.
        • Paltiel O.
        • et al.
        Long-term mortality after preeclampsia.
        Epidemiology. 2005; 16: 206-215
        • Manten G.T.
        • Sikkema M.J.
        • Voorbij H.A.
        • Visser G.H.
        • Bruinse H.W.
        • Franx A.
        Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction.
        Hypertens Pregnancy. 2007; 26: 39-50
        • Berends A.L.
        • de Groot C.J.
        • Sijbrands E.J.
        • et al.
        Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.
        Hypertension. 2008; 51: 1034-1041
        • Davis E.F.
        • Lazdam M.
        • Lewandowski A.J.
        • et al.
        Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review.
        Pediatrics. 2012; 129: e1552-e1561
        • Lawlor D.A.
        • Macdonald-Wallis C.
        • Fraser A.
        • et al.
        Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children.
        Eur Heart J. 2012; 33: 335-345
        • Tenhola S.
        • Rahiala E.
        • Martikainen A.
        • Halonen P.
        • Voutilainen R.
        Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia.
        J Clin Endocrinol Metab. 2003; 88: 1217-1222
        • Chambers J.C.
        • Fusi L.
        • Malik I.S.
        • Haskard D.O.
        • De Swiet M.
        • Kooner J.S.
        Association of maternal endothelial dysfunction with preeclampsia.
        JAMA. 2001; 285: 1607-1612
        • Magnussen E.B.
        • Vatten L.J.
        • Lund-Nilsen T.I.
        • Salvesen K.A.
        • Davey Smith G.
        • Romundstad P.R.
        Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study.
        BMJ. 2007; 335: 978
        • Craici I.
        • Wagner S.
        • Garovic V.D.
        Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?.
        Ther Adv Cardiovasc Dis. 2008; 2: 249-259
        • Vatten L.J.
        • Skjaerven R.
        Is pre-eclampsia more than one disease?.
        BJOG. 2004; 111: 298-302